Article
Sanofi Q1 profit buoyed by better-than-expected Dupixent sales
Rating:
0.0
Views:
78
Likes:
1
Library:
1
French drugmaker Sanofi on Thursday posted better-than-expected earnings for the first quarter as continued gains from anti-inflammatory drug Dupixent more than offset declining sales from an established multiple sclerosis drug.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value